Theoretical Models of Aspartic Proteases: Active Site Properties, Dimer Stability and Interactions with Model Inhibitors
HIV-1 PR, an aspartic proteinase (AP), is recognized now as an important target for designing effective and selective drugs which could arrest the late stages in replication of HIV-1, the causative agent of AIDS.1 Selectivity of such enzyme inhibitors is required in addition to high affinity. The most spectacular difference between HIV-1 PR, a retroviral enzyme, and the cellular AP, is the smaller size and dimeric structure of the former. The conservation of active site residues, Asp-Thr/Ser-Gly, seems to eliminate the ability to design selective active-site inhibitors for AP.2 This is, however, achieved by accumulated experience with the construction of novel renin inhibitors.
KeywordsActive Site Residue Aspartic Proteinase Model Inhibitor Renin Inhibitor Dime Stability
Unable to display preview. Download preview PDF.